| چکیده انگلیسی مقاله |
The Economic Burden of Glaucoma in Iran, 2012 Ali Asghar Shakeri (MSc)1 , Ali Kazemi Karyani (PhD Candidate)2, Ali Akbari Sari (MD, PhD)3*, Ghasem Fakhraei (MD)4, Ahmad Fayazbakhsh (MD, PhD)5, Alireza Yoosefi (MSc)6 1 Department of health management and economics, school of public health, Tehran University of Medical Sciences, Tehran, Iran. 2 Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran. 3 Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 4 Department of ophthalmology of Farabi Hospital, Tehran University of Medical Sciences, Tehran, Iran. 5 Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 6 Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Abstract Introduction: Glaucoma imposes direct and indirect costs on societies. The current study aimed at estimating the economic burden of glaucoma in Iran in 2012. Methods: The study was performed based on the partial economic evaluation method. The prevalence-based approach and bottom-up method were used. The human capital approach was used to calculate indirect costs. Required data were obtained from interview with 10 eye specialists and 100 patients, literature review, and review of 100 medical records of patients at Farabi Hospital in Tehran. Results: The total cost of the disease was $US 1,746,412.35, which 77.09% of the costs were related to direct cost; indirect costs accounted for 22.91% of the total costs. The total cost of hospitalization included the highest share of direct medical costs (74.4%). Average cost of outpatient for surgical and nonsurgical groups were $US 14.87 and $US 14.11, respectively. The average cost of hospitalization was $US 180.54. Conclusions: Glaucoma imposed high economic burden on Iran. Proper planning for the early treatment of the disease and prevention of its complications could reduce costs of treatment and disability. Keywords: Glaucoma; Economic Burden; Cost of Illness; Iran Please cite this article as follows: Shakeri AA, Kazemi Karyani A, Akbari Sari A, Fakhraei Gh , Fayazbakhsh A, Yoosefi A. The Economic Burden of Glaucoma in Iran, 2012. Hakim Health Sys Res 2017; 19(4): 182-192 *Corresponding Author: Department of health management and economics, school of public health, Tehran University of Medical Sciences, Tehran, Iran. Tel: +98-21-88989129, Email: akbarisari@tums.ac.ir |